EAM
VYGR icon

Erste Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Erste Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
638,900
-456,241
-42% -$1.73M 0.02% 365
2026
Q1 		$4.24M Sell
1,095,141
-100,000
-8% -$394K 0.04% 286
2025
Q4 		$4.72M Buy
1,195,141
+78,348
+7% +$347K 0.04% 280
2025
Q3 		$5.26M Hold
1,116,793
– – 0.05% 248
2025
Q2 		$3.44M Hold
1,116,793
– – 0.03% 321
2025
Q1 		$3.83M Buy
1,116,793
+58,415
+6% +$273K 0.05% 249
2024
Q4 		$5.94M Hold
1,058,378
– – 0.07% 223
2024
Q3 		$6.19M Hold
1,058,378
– – 0.07% 218
2024
Q2 		$8.36M Hold
1,058,378
– – 0.11% 171
2024
Q1 		$9.9M Hold
1,058,378
– – 0.13% 156
2023
Q4 		$9M Hold
1,058,378
– – 0.13% 160
2023
Q3 		$8.2M Hold
1,058,378
– – 0.14% 160
2023
Q2 		$12.1M Sell
1,058,378
-30,000
-3% -$310K 0.21% 122
2023
Q1 		$8.39M Sell
1,088,378
-50,000
-4% -$398K 0.16% 154
2022
Q4 		$6.86M Hold
1,138,378
– – 0.14% 163
2022
Q3 		$6.76M Hold
1,138,378
– – 0.15% 163
2022
Q2 		$6.73M Sell
1,138,378
-84,522
-7% -$571K 0.15% 169
2022
Q1 		$9.36M Sell
1,222,900
-40,000
-3% -$178K 0.18% 144
2021
Q4 		$3.59M Buy
1,262,900
+300,000
+31% +$1.02M 0.06% 245
2021
Q3 		$2.55M Buy
962,900
+220,000
+30% +$715K 0.05% 258
2021
Q2 		$3.07M Buy
742,900
+150,000
+25% +$680K 0.06% 252
2021
Q1 		$2.81M Buy
592,900
+205,000
+53% +$1.4M 0.07% 232
2020
Q4 		$2.82M Buy
387,900
+45,000
+13% +$433K 0.08% 235
2020
Q3 		$3.68M Hold
342,900
– – 0.13% 180
2020
Q2 		$4.3M Buy
342,900
+9,000
+3% +$105K 0.17% 141
2020
Q1 		$3.03M Buy
333,900
+13,000
+4% +$149K 0.18% 144
2019
Q4 		$4.33M Buy
320,900
+15,000
+5% +$218K 0.19% 125
2019
Q3 		$5.26M Buy
305,900
+7,000
+2% +$147K 0.28% 102
2019
Q2 		$8.08M Hold
298,900
– – 0.43% 59
2019
Q1 		$5.71M Buy
298,900
+240,000
+407% +$3.13M 0.32% 84
2018
Q4 		$529K Buy
+58,900
New +$756K 0.04% 304

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Erste Asset Management's VYGR Position: Q2 2026 in Review

Erste Asset Management reduced its Voyager Therapeutics (VYGR) stake by 42% in Q2 2026, selling an estimated $1.73M and leaving 638,900 shares worth $2.29M. The position accounts for 0.02% of the portfolio, ranked #365.

Erste Asset Management first reported a position in VYGR in Q4 2018 and has held it in 31 quarters since. The position peaked at $12.1M in Q2 2023. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Erste Asset Management held 638,900 shares of Voyager Therapeutics worth $2.29M as of Q2 2026.
  • Erste Asset Management sold 456,241 Voyager Therapeutics shares in Q2 2026, an estimated $1.73M.
  • Voyager Therapeutics made up 0.02% of Erste Asset Management's portfolio in Q2 2026, its #365 holding.
  • Erste Asset Management first reported a position in Voyager Therapeutics in Q4 2018 and has held it in 31 quarters since.
  • Erste Asset Management's Voyager Therapeutics position peaked at $12.1M in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.